Skin Reactions Related to Thoracic Implantable Chamber Dressings
ConditionSkin Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorInstitut Curie
About this trial
Prospective, multicenter cohort of 500 patients newly treated with systemic chemotherapy with CCI. The main objective of this study is to measure the incidence of skin reactions related to thoracic implantable chamber dressings.
Eligibility criteria
Qualifiers
Patients over 18 years of age
New chemotherapy patients (1st line of treatment only)
Thoracic PAC
Disqualifiers
PICC Line and femoral PAC;
Patients undergoing treatment with bi-specific antibodies (e.g. tebentafusp);
Disunion requiring treatment
Patients treated for hematological cancer;
Trial design
Treatments tested in this trial
- Not listed
Trial groups
500 Participants
are grouped into 1 trial groupLocations
3France
Institut Curie75248, Paris France
French Polynesia
Centre Hospitalier de Polynésie Française CHPF98716, Pirae French Polynesia
Hôpital Uturoa98735, Uturoa French Polynesia
Sponsors and collaborators
Institut Curie
Lead sponsor
Source ClinicalTrials.gov